These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7396470)

  • 1. New schedule for tobramycin administration.
    Lawson RD; Bodey GP; Pan T; Smith TL
    Antimicrob Agents Chemother; 1980 May; 17(5):834-7. PubMed ID: 7396470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.
    Sánchez-Alcaraz A; Vargas A; Quintana MB; Rocher A; Querol JM; Poveda JL; Hermenegildo M
    J Clin Pharm Ther; 1998 Oct; 23(5):367-73. PubMed ID: 9875685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin therapy of serious infections. Pharmacological aspects and side effects.
    Bruun JN; Eng J; Arnesen AR
    Scand J Infect Dis; 1981; 13(1):59-64. PubMed ID: 7244560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematically individualizing tobramycin dosage regimens.
    Cipolle RJ; Seifert RD; Zaske DE; Strate RG
    J Clin Pharmacol; 1980 Oct; 20(10):570-80. PubMed ID: 7440765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on tobramycin using intravenous drip infusion (author's transl)].
    Saito A; Kikuiri T; Tomizawa M; Ujiie A; Kinoshita Y
    Jpn J Antibiot; 1981 Sep; 34(9):1255-62. PubMed ID: 7328750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose tobramycin combined with clindamycin or lincomycin in the treatment of septic peritonitis and intraabdominal sepsis.
    Muth L; Edén T
    Acta Chir Scand; 1981; 147(5):339-46. PubMed ID: 7324760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.
    Manley HJ; Bailie GR; Frye R; Hess LD; McGoldrick MD
    J Am Soc Nephrol; 2000 Jul; 11(7):1310-1316. PubMed ID: 10864588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of tobramycin and gentamicin by the intravenous route every 6 hr in patients with normal renal function.
    Setia U; Gross PA
    J Infect Dis; 1976 Aug; 134 Suppl():S125-9. PubMed ID: 972270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fundamental and clinical studies on tobramycin by intravenous drip infusion (author's transl)].
    Toyonaga Y; Kurosu Y; Hori M
    Jpn J Antibiot; 1981 Nov; 34(11):1436-46. PubMed ID: 7334577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post-operative septic shock patients.
    Oparaoji EC; Siram S; Shoheiber O; Cornwell EE; Mezghebe HM
    J Clin Pharm Ther; 1998 Jun; 23(3):185-90. PubMed ID: 9831969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serum.
    Gillett AP; Falk RH; Andrews J; Wise R; Melikian V
    J Infect Dis; 1976 Aug; 134 Suppl():S110-3. PubMed ID: 985661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobramycin in patients with various infections: a clinical evaluation.
    Atterholm I; Hedström SA; Kahlmeter G; Kamme C
    Scand J Infect Dis; 1978; 10(3):229-34. PubMed ID: 362517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single daily doses of tobramycin in therapy of urinary tract infections.
    Landes RR
    J Infect Dis; 1976 Aug; 134 Suppl():S142-5. PubMed ID: 972273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of tobramycin in children.
    Hoecker JL; Pickering LK; Swaney J; Kramer WG; van Eys J; Feldman S; Kohl S
    J Infect Dis; 1978 May; 137(5):592-6. PubMed ID: 659916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobramycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 1997 Oct; 62(4):392-9. PubMed ID: 9357390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin sulfate elimination in premature infants.
    Arbeter AM; Saccar CL; Eisner S; Sarni E; Yaffe SJ
    J Pediatr; 1983 Jul; 103(1):131-5. PubMed ID: 6864378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.